Assessments of the relative desirability or acceptability to patients of specified alternatives or choices among outcomes or other attributes that differ among alternative health interventions. The methods for generating PPI may be qualitative, quantitative, or mixed methods.

FDA: Patient-Focused Drug Development Glossary | F.D.A. Guidance on Patient Preference Information